These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 3923146
41. Plasminogen activator inhibitors in plasma and platelets from patients with recurrent venous thrombosis and pregnant women. Häggroth L, Mattsson C, Felding P, Nilsson IM. Thromb Res; 1986 Jun 01; 42(5):585-94. PubMed ID: 3087015 [Abstract] [Full Text] [Related]
42. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology. Gris JC, Neveu S, Mares P, Biron C, Hedon B, Schved JF. J Lab Clin Med; 1993 Nov 01; 122(5):606-15. PubMed ID: 8228580 [Abstract] [Full Text] [Related]
44. Activities of antiplasmin and antiplasminogen activator in serous middle ear effusions. Hamaguchi Y, Ohi M, Sakakura Y, Miyoshi Y. Ann Otol Rhinol Laryngol; 1985 Nov 01; 94(3):293-6. PubMed ID: 3925865 [Abstract] [Full Text] [Related]
45. Inhibitory mechanism of serpins: loop insertion forces acylation of plasminogen activator by plasminogen activator inhibitor-1. Kvassman JO, Verhamme I, Shore JD. Biochemistry; 1998 Nov 03; 37(44):15491-502. PubMed ID: 9799512 [Abstract] [Full Text] [Related]
46. A novel fast inhibitor to tissue plasminogen activator in plasma, which may be of great pathophysiological significance. Wiman B, Chmielewska J. Scand J Clin Lab Invest Suppl; 1985 Nov 03; 177():43-7. PubMed ID: 3934745 [Abstract] [Full Text] [Related]
48. Rapid purification of a high-affinity plasminogen activator from human blood plasma by specific adsorption on fibrin/Celite. Husain SS, Lipinski B, Greuwich V. Proc Natl Acad Sci U S A; 1981 Jul 03; 78(7):4265-9. PubMed ID: 6270665 [Abstract] [Full Text] [Related]
51. Simultaneous determination of free tissue-type and free urokinase-type plasminogen activators in biological fluids by a solid-phase immunoassay. Kuo BS, Bjornsson TD. Anal Biochem; 1993 Feb 15; 209(1):70-8. PubMed ID: 8465964 [Abstract] [Full Text] [Related]
53. Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis. Björquist P, Ehnebom J, Inghardt T, Hansson L, Lindberg M, Linschoten M, Strömqvist M, Deinum J. Biochemistry; 1998 Feb 03; 37(5):1227-34. PubMed ID: 9477948 [Abstract] [Full Text] [Related]
55. Plasminogen activators in human malignant melanoma. Markus G, Kohga S, Camiolo SM, Madeja JM, Ambrus JL, Karakousis C. J Natl Cancer Inst; 1984 Jun 03; 72(6):1213-22. PubMed ID: 6374238 [Abstract] [Full Text] [Related]
56. Tissue-type plasminogen activator and fast-acting plasminogen activator inhibitor in plasma. Verheijen JH. Methods Enzymol; 1988 Jun 03; 163():302-9. PubMed ID: 3148827 [No Abstract] [Full Text] [Related]
57. Standardization of methods for measuring plasminogen activator inhibitor activity in human plasma. Chandler WL, Loo SC, Nguyen SV, Schmer G, Stratton JR. Clin Chem; 1989 May 03; 35(5):787-93. PubMed ID: 2498016 [Abstract] [Full Text] [Related]
58. Fibrin autography of plasminogen activator by electrophoretic transfer into fibrin agar gels. Brunner G, Schirrmacher V. Anal Biochem; 1988 Feb 01; 168(2):411-6. PubMed ID: 3364738 [Abstract] [Full Text] [Related]